The diverse panel discussed the difficulties in neonatal drug development and the legislation currently moving through the U.S. Senate, The Promoting Life-Saving New Therapies for Neonates Act. In conclusion, the panel encouraged stakeholders to use this simple form send a letter to their Members of Congress urging them to cosponsor the legislation.
- Dr. Jonathan Davis, Vice-Chair of Pediatrics and Chief of Newborn Medicine at Tufts Medical Center, Chair of the Neonatal Advisory Committee at the Food and Drug Administration (FDA);
- Allyson Kayton, MSN, APRN, NNP-BC, Neonatal Nurse Practitioner, Health Policy & Advocacy Committee at the National Association of Neonatal Nurses (NANN);
- Keira Sorrells, Co-founder Preemie Parent Alliance (PPA) and Founder of Zoe Rose Memorial Foundation, mother of preemie triplets;
- Jennifer Degl, Writer for The Huffington Post and Author of From Hope to Joy, a story chronicling her experience in the NICU after giving birth to her micro-preemie daughter, Joy.